Comment on the Impact for Stenocare in Regards to the Danish Health Minister’s Decision to Propose a Permanent Legalization of Medical Cannabis
Medical cannabis has been legal in Denmark under a pilot program since 2018 during a trial period that was set to expire in December 2025. However, on November 19th, the Danish Health Minister invited political parties to discuss the permanent legalization of medical cannabis in Denmark, where STENOCARE has three medical cannabis oil products approved for sale. The intention of the government is to proceed with the legalization.
Read Analyst Group’s comment here
About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.
Read more about Analyst Group
This is a press release from Analyst Group regarding the publication of a comment on STENOCARE. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.